| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
OBI Pharma Inc (TWO: 4174)
4174 Technical Analysis
5
| As on 24th Apr 2025 4174 STOCK Price closed @ 42.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 69.44 & Strong Sell for SHORT-TERM with Stoploss of 79.35 we also expect STOCK to react on Following IMPORTANT LEVELS. |
4174STOCK Price
| Open | 42.20 | Change | Price | % |
| High | 42.20 | 1 Day | -4.65 | -9.93 |
| Low | 42.20 | 1 Week | -6.85 | -13.97 |
| Close | 42.20 | 1 Month | -15.00 | -26.22 |
| Volume | 302966 | 1 Year | -39.30 | -48.22 |
| 52 Week High 90.60 | 52 Week Low 45.40 | ||||
TWO Taiwan Most Active Stocks
| 6140 | 45.10 | 0.89% |
| 6148 | 67.40 | 3.69% |
| 8088 | 33.85 | 0.30% |
| 5439 | 133.00 | 1.92% |
| 4541 | 49.55 | -2.08% |
| 5201 | 47.75 | 5.29% |
| 3264 | 74.00 | 5.71% |
| 8096 | 52.50 | -3.67% |
| 1785 | 52.50 | 0.96% |
| 1815 | 27.10 | -1.45% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 4174 Daily Charts |
4174 Intraday Charts |
Whats New @ Bazaartrend |
4174 Free Analysis |
|
|
4174 Important Levels Intraday
| RESISTANCE | 42.20 |
| RESISTANCE | 42.20 |
| RESISTANCE | 42.20 |
| RESISTANCE | 42.20 |
| RESISTANCE | 42.20 |
| RESISTANCE | 42.20 |
| RESISTANCE | 42.20 |
| RESISTANCE | 42.20 |
4174 Forecast April 2025
| 4th UP Forecast | 80.74 |
| 3rd UP Forecast | 68.38 |
| 2nd UP Forecast | 60.74 |
| 1st UP Forecast | 53.1 |
| 1st DOWN Forecast | 31.3 |
| 2nd DOWN Forecast | 23.66 |
| 3rd DOWN Forecast | 16.02 |
| 4th DOWN Forecast | 3.66 |
4174 Weekly Forecast
| 4th UP Forecast | 49.91 |
| 3rd UP Forecast | 47.44 |
| 2nd UP Forecast | 45.91 |
| 1st UP Forecast | 44.38 |
| 1st DOWN Forecast | 40.02 |
| 2nd DOWN Forecast | 38.49 |
| 3rd DOWN Forecast | 36.96 |
| 4th DOWN Forecast | 34.49 |
4174 Forecast2025
| 4th UP Forecast | 139.9 |
| 3rd UP Forecast | 108.57 |
| 2nd UP Forecast | 89.2 |
| 1st UP Forecast | 69.83 |
| 1st DOWN Forecast | 14.57 |
| 2nd DOWN Forecast | -4.8 |
| 3rd DOWN Forecast | -24.17 |
| 4th DOWN Forecast | -55.5 |
OBI Pharma Inc ( TWO Taiwan Symbol : 4174 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
4174 Business Profile
OBI Pharma, Inc., a bio-pharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. It offers Adagloxad Simolenin (OBI-822), a breast cancer active immunity anti-cancer drug for generating antibody against tumor carbohydrate antigen Globo H; OBI-833, an immunity anti-cancer drug for the treatment of lung cancer; OBI-866 SSEA-4, an active immuno-oncology drug; OBI-888, a passive immunotherapy monoclonal antibody designed for targeting Globo H; OBI-999, an antibody drug conjugate; OBI-898 SSEA4, a passive immunity monoclonal antibody; OBI-998 SSEA4, an antibody small molecule drug complex, which targets toxic drugs to malignant tumors; OBI-3424, a micromolecule chemotherapy prodrug; and OBI-858, a clostridium botulinum toxin. The company was founded in 2002 and is based in Taipei, Taiwan. Address: No. 3, Park Street, Taipei, Taiwan, 115
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service